- - Event expected to bring over 3,300 life science dealmakers to Bavaria
CARLSBAD, California and MUNICH, July 7, 2015 /PRNewswire/ -- The twenty-first annual BIO-Europe® international life science partnering conference will be held in Munich, Germany, November 2–4, 2015. Organized by EBD Group, the event is co-hosted by BioM Biotech Cluster Development, the Bavarian Ministry of Economic Affairs and Media, Energy and Technology, and Cluster Biotechnology Bavaria.
Bavaria is an ideal location because it is home to a broad spectrum of high-capacity industries including life sciences and is a leading business region in Europe. There are 270 life science companies in the Munich biotech cluster, characterized by innovative small and medium-sized biotech companies and a focus on new therapeutics and diagnostics, "omics"-technologies, personalized medicine and biomarker research.
"Collaboration is the key to success in today's rapidly changing drug development culture," said Horst Domdey, Managing Director of BioM Biotech Cluster Development GmbH, the main office for biotechnology in Bavaria. "We welcome BIO-Europe to Munich, the hotspot for biopharmaceutical innovation in Europe. We are keen to showcase again to key international life science leadership what our legendary hospitality means in combination with our age-old motto: innovation by tradition."
BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry and is facilitated by EBD Group's partneringONE®, the gold standard one-to-one networking solution for the life sciences.
"We are pleased to return to Munich this year as it is an extremely active life science cluster with a rich history and tradition in biotechnology research and innovation," said Anna Chrisman, Group Managing Director, EBD Group.
A highlight of the event are the company presentations by early stage projects, innovative startups, established biotechs and midsize pharma companies. The deadline to submit an application to present is July 31, 2015. Apply now.
International pharma companies already confirmed to attend include AbbVie, Almirall, Amgen, AstraZeneca, Baxalta, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, GSK, Johnson & Johnson, Lilly, Merck Serono, MSD, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi, Shire, and Takeda.
The 2014 edition featured 17,902 one-to-one partnering meetings. Over 3,200 delegates from 1,772 companies representing 54 countries attended. There were 162 company presentations with 4,032 licensing opportunities on offer, and 98 exhibitors at the event.
Additional links and information:
Follow BIO-Europe 2015 on Twitter: @EBDGroup (hashtag: #BEU15).
Online Press Kit service for BIO-Europe 2015 is available from PR Newswire to enhance your public relations efforts.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group's conferences are run with the support of leading corporations and international trade associations and include:
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.
